Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
SGT-003
DRUG
2 trials
Sponsors
Solid Biosciences Inc.
Conditions
Duchenne Muscular Dystrophy
Phase 1
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
Recruiting
NCT06138639
Solid Biosciences Inc.
Duchenne Muscular Dystrophy
Start: 2024-05-06
End: 2031-05-06
Target: 60
Updated: 2026-07-08
Phase 3
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
Recruiting
NCT07160634
Solid Biosciences Inc.
Duchenne Muscular Dystrophy
Start: 2025-10-22
End: 2034-01-01
Target: 80
Updated: 2026-08-13